Thomas Steyer’s Precigen PGEN Stock Holding History

Thomas Steyer’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-50,000	Closed	-$194K	–	160
2026 Q1	$194K	Hold	50,000	–	–	﹤0.01%	149
2025 Q4	$209K	Buy	+50,000	New	+$193K	﹤0.01%	135

Other funds holding PGEN

PCM

Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Thomas Steyer's PGEN Position: Q2 2026 in Review

Thomas Steyer sold out of Precigen (PGEN) in Q2 2026, closing a stake of 50,000 shares — an estimated $194K sold.

Thomas Steyer first reported a position in PGEN in Q4 2025 and held it in 2 quarters. The position peaked at $209K in Q4 2025. 209 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

Thomas Steyer reported no remaining Precigen position as of Q2 2026 after selling out during the quarter.
Thomas Steyer sold 50,000 Precigen shares in Q2 2026, an estimated $194K.
Thomas Steyer first reported a position in Precigen in Q4 2025 and held it in 2 quarters.
Thomas Steyer's Precigen position peaked at $209K in Q4 2025.
209 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Farallon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.